CA2599252C - Carnitine-containing peritoneal dialysis solution having improved biocompatibility - Google Patents

Carnitine-containing peritoneal dialysis solution having improved biocompatibility Download PDF

Info

Publication number
CA2599252C
CA2599252C CA2599252A CA2599252A CA2599252C CA 2599252 C CA2599252 C CA 2599252C CA 2599252 A CA2599252 A CA 2599252A CA 2599252 A CA2599252 A CA 2599252A CA 2599252 C CA2599252 C CA 2599252C
Authority
CA
Canada
Prior art keywords
carnitine
glucose
peritoneal dialysis
pds
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2599252A
Other languages
English (en)
French (fr)
Other versions
CA2599252A1 (en
Inventor
Arduino Arduini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corequest Sagl
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CA2599252A1 publication Critical patent/CA2599252A1/en
Application granted granted Critical
Publication of CA2599252C publication Critical patent/CA2599252C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
CA2599252A 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility Active CA2599252C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPCT/IT2005/000130 2005-03-10
IT2005000130 2005-03-10
PCT/EP2006/060162 WO2006094900A1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Publications (2)

Publication Number Publication Date
CA2599252A1 CA2599252A1 (en) 2006-09-14
CA2599252C true CA2599252C (en) 2013-07-30

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2599252A Active CA2599252C (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Country Status (19)

Country Link
US (1) US20080138443A1 (enExample)
EP (1) EP1858504B1 (enExample)
JP (2) JP4717110B2 (enExample)
KR (1) KR101324920B1 (enExample)
AR (1) AR054015A1 (enExample)
AT (1) ATE539742T1 (enExample)
CA (1) CA2599252C (enExample)
CY (1) CY1112794T1 (enExample)
DK (1) DK1858504T3 (enExample)
ES (1) ES2380168T3 (enExample)
HR (1) HRP20120177T1 (enExample)
ME (1) ME02948B (enExample)
MX (1) MX2007010814A (enExample)
PL (1) PL1858504T3 (enExample)
PT (1) PT1858504E (enExample)
RS (1) RS52237B (enExample)
SI (1) SI1858504T1 (enExample)
TW (1) TWI388318B (enExample)
WO (1) WO2006094900A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) * 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
US6537976B1 (en) 1997-08-07 2003-03-25 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
KR100642731B1 (ko) * 1999-10-11 2006-11-03 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 의료용 용액에서 삼투제로서 ｌ-카르니틴 및 그의알카노일 유도체의 용도
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
CA2508596A1 (en) 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
RS52237B (sr) 2012-10-31
DK1858504T3 (da) 2012-04-30
PT1858504E (pt) 2012-04-10
SI1858504T1 (sl) 2012-04-30
JP2010207630A (ja) 2010-09-24
CA2599252A1 (en) 2006-09-14
TW200714279A (en) 2007-04-16
KR20070116630A (ko) 2007-12-10
EP1858504A1 (en) 2007-11-28
ES2380168T3 (es) 2012-05-09
WO2006094900A1 (en) 2006-09-14
US20080138443A1 (en) 2008-06-12
ATE539742T1 (de) 2012-01-15
MX2007010814A (es) 2007-11-07
EP1858504B1 (en) 2012-01-04
PL1858504T3 (pl) 2012-05-31
KR101324920B1 (ko) 2013-11-01
HRP20120177T1 (hr) 2012-03-31
AR054015A1 (es) 2007-05-30
JP4717110B2 (ja) 2011-07-06
CY1112794T1 (el) 2016-02-10
JP2008532601A (ja) 2008-08-21
ME02948B (me) 2012-10-31
JP5366894B2 (ja) 2013-12-11
TWI388318B (zh) 2013-03-11

Similar Documents

Publication Publication Date Title
Kletzmayr et al. Anemia and carnitine supplementation in hemodialyzed patients
TORIU et al. Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
Topley et al. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.
JPH06199663A (ja) 精神分裂病治療法
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
US20090062387A1 (en) Method of preventing nephrocalcinosis
CA2788865A1 (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurenine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
CN110327367A (zh) 含有硝酸盐和维生素的组合物、其制备方法、制剂及其用途
WO2013151341A1 (en) Injectable composition comprising phosphatidylcholine and method for preparing thereof
JP5366894B2 (ja) 生体適合性が改善されたカルニチンを含有する腹膜透析液
CA2631740A1 (en) Methods and compositions for the treatment of disease
JP3182564B2 (ja) 栄養組成物
WO2019035989A1 (en) PREVENTION OF CALCIUM OXALATE RENAL CALCULATIONS BY POTASSIUM HYDROXYCITRATE
WO2025103336A1 (zh) 三乙酰基-3-羟基苯基腺苷在制备运动模拟药物中的应用
ITRM990483A1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologie renali di tipo tossico e funzionale.
MXPA02000912A (es) Uso de l-carnitina y sus derivados alcanoilo para la preparacion de un medicamento util para el tratamiento de pacientes que sufren nefropatias diabeticas o por insuficiencia metabolica.
CA2082275A1 (en) Pharmaceutical composition
JP2876547B2 (ja) 抗クル病剤
US20080095865A1 (en) Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance
US11964087B2 (en) Peritoneal dialysis solution
JP2009084211A (ja) 神経細胞賦活組成物
Tungsanga et al. Utilization of alpha-ketoisocaproate for protein synthesis in uremic rats
WO2004105679A2 (en) Use of a nutritional composition for treating hypertension
ITRM20000107A1 (it) Composizione per la prevenzione e/o il trattamento degli effetti citotossici indotti dall'uso di agenti immunosoppressori.
JP2008133271A (ja) 生活習慣病の予防および／または治療用組成物

Legal Events

Date Code Title Description
EEER Examination request